ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

NLSP NLS Pharmaceutics Ltd

0.1299
-0.0025 (-1.89%)
Apr 26 2024 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 437,882
Bid Price 0.125
Ask Price 0.1457
News -
Day High 0.1464

Low
0.113

52 Week Range

High
1.53

Day Low 0.1211
Share Name Share Symbol Market Stock Type
NLS Pharmaceutics Ltd NLSP NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
-0.0025 -1.89% 0.1299 18:54:31
Open Price Low Price High Price Close Price Previous Close
0.123 0.1211 0.1464 0.1367 0.1324
Trades Shares Traded VWAP Financial Volume Average Volume 52 Week Range
669 437,882 US$ 0.1356264 US$ 59,388 - 0.113 - 1.53
Last Trade Type Quantity Price Currency
18:54:31 formt 854 US$ 0.1299 USD

NLS Pharmaceutics Ltd Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
US$ 4.21M - - - -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

NLS Pharmaceutics News

Date Time Source News Article
3/11/202415:01Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and..
2/23/202415:00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and..
1/12/202416:03Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and..
12/29/202315:30Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and..
12/22/202315:02Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and..
12/06/202315:44Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and..
12/04/202315:45Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and..
12/04/202315:00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and..
12/01/202306:35Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and..
11/16/202315:05Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and..
10/25/202315:30Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and..
10/25/202308:02Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and..
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No NLSP Message Board. Create One! See More Posts on NLSP Message Board See More Message Board Posts

Historical NLSP Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week0.13250.14640.1130.1303068230,446-0.0026-1.96%
1 Month0.1890.19290.1130.1455245264,063-0.0591-31.27%
3 Months0.500.520.1130.1725251616,264-0.3701-74.02%
6 Months0.510.74230.1130.3712135570,618-0.3801-74.53%
1 Year1.471.530.1130.492072347,778-1.34-91.16%
3 Years3.513.890.1131.35593,208-3.38-96.30%
5 Years2.99657.350.1132.64795,856-2.87-95.66%

NLS Pharmaceutics Description

NLS Pharmaceutics Ltd is a biopharmaceutical company. It is engaged in the discovery and development of life-improving drug therapies to treat rare and complex CNS disorders. It focuses on developing therapeutics for the treatment of neurobehavioral and neurocognitive disorders. The company's tangible assets are held in the United States.

Your Recent History

Delayed Upgrade Clock